Search results for "colonic"

showing 10 items of 329 documents

Isolated Metachronous Splenic Metastasis from Colon Cancer: Possible Explanations for This Rare Entity

2017

The incidence of splenic metastases secondary to colorectal cancer is very low; these lesions have been more frequently reported as secondary to breast, lung, and ovarian cancer. Splenic metastases are particularly common in melanoma; their incidence has been reported as being as high as 34% at autopsy [1]. Most cases of secondary splenic metastases have been described in patients with tumors of the left colon while only few cases being reported as originating from right colon tumors (Table 1). The finding of a splenic mass in the absence of a history of malignancy suggests a primary lesion (lymphoma, hematoma, etc.), while a history of oncological disease raises the possibility of a second…

Oncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentMEDLINESplenic Neoplasm030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansNeoplasm MetastasisAgedbusiness.industrySplenic NeoplasmsRare entityGastroenterologymedicine.diseaseRadiation therapySettore MED/18 - Chirurgia GeneraleOncology; GastroenterologyOncology030220 oncology & carcinogenesisColonic NeoplasmsFemalebusinessSplenic metastasis
researchProduct

Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE…

2021

International audience; Aim Neoadjuvant chemotherapy has proven valuable in locally advanced resectable colon cancer (CC) but its effect on oncological outcomes is uncertain. The aim of the present paper was to report 3-year oncological outcomes, representing the secondary endpoints of the PRODIGE 22 trial. Method PRODIGE 22 was a randomized multicentre phase II trial in high-risk T3, T4 and/or N2 CC patients on CT scan. Patients were randomized between 6 months of adjuvant FOLFOX (upfront surgery) or perioperative FOLFOX (four cycles before surgery and eight cycles after; FOLFOX perioperative). In wild-type RAS patients, a third arm testing perioperative FOLFOX-cetuximab was added. The pri…

Oncologymedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancer[SDV]Life Sciences [q-bio]medicine.medical_treatmentPopulationLeucovorinsurvival03 medical and health sciences0302 clinical medicineFOLFOXInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineClinical endpointHumanseducationNeoplasm StagingColectomyeducation.field_of_studybusiness.industryHazard ratioGastroenterologyPerioperativecolectomyPrognosisInterim analysismedicine.diseaseNeoadjuvant Therapydigestive system diseasescolon cancerChemotherapy Adjuvant030220 oncology & carcinogenesisColonic Neoplasms030211 gastroenterology & hepatologyFluorouracilNeoplasm Recurrence Localbusinessneoadjuvant chemotherapyFollow-Up Studiesmedicine.drugColorectal Disease
researchProduct

S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Pati…

2021

<b><i>Background:</i></b> Fatigue is a common distressing symptom for patients living with chronic or acute diseases, including liver disorders and cancer (<i>Cancer-Related Fatigue</i>, CRF). Its etiology is multifactorial, and some hypotheses regarding the pathogenesis are summarized, with possible shared mechanisms both in cancer and in chronic liver diseases. A deal of work has investigated the role of a multifunctional molecule in improving symptoms and outcomes in different liver dysfunctions and associated symptoms, including chronic fatigue: S-adenosylmethionine (SAM; AdoMet). The aim of this work is actually to consider its role also in oncologic…

Oncologymedicine.medical_specialtyS-AdenosylmethionineBevacizumabCancer-related fatigueColorectal cancerAdoMetFOLFOXInternal medicineSurveys and QuestionnairesDrug DiscoverymedicineHumansPharmacology (medical)Cancer-related fatigueFatiguePharmacologybusiness.industryCancerChronic fatigueGeneral Medicinemedicine.diseaseCancer treatment toxicityOxaliplatinColon cancerOxaliplatinRegimenInfectious DiseasesOncologyFunctional Assessment of Chronic Illnesses Therapy-FatigueColonic NeoplasmsDietary SupplementsQuality of Lifemedicine.symptombusinessmedicine.drugChemotherapy
researchProduct

Robotic-assisted right colectomy. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)

2022

: Twenty-seven experts under the aegis of the French Association of Surgery (AFC) offer this reference system with formalized recommendations concerning the performance of right colectomy by robotic approach (RRC). For RRC, experts suggest patient installation in the so-called "classic" or "suprapubic" setup. For patients undergoing right colectomy for a benign pathology or cancer, RRC provides no significant benefit in terms of intra-operative blood loss, intra-operative complications or conversion rate to laparotomy compared to laparoscopy. At the same time, RRC is associated with significantly longer operating times. Data from the literature are insufficient to define whether the robot f…

Operative TimeRight colectomyGeneral MedicineRecommendationsLength of StayTreatment OutcomeRobotic Surgical ProceduresMinimally invasive surgeryColonic NeoplasmsOncological colonic resectionQuality of LifeSurgery by robotic approachHumansLaparoscopyColectomyRetrospective StudiesJournal of Visceral Surgery
researchProduct

Imaging standardisation in metastatic colorectal cancer: a joint EORTC-ESOI-ESGAR expert consensus recommendation

2022

Background: Treatment monitoring in metastatic colorectal cancer (mCRC) relies on imaging to evaluate the tumor burden. Response Evaluation Criteria in Solid Tumors (RECIST) provide a framework on reporting and interpretation of imaging findings yet offer no guidance on a standardized imaging protocol tailored to mCRC patients. Imaging protocol heterogeneity remains a challenge for the reproducibility of conventional imaging endpoints and is an obstacle for research on novel imaging endpoints. Patients and methods: Acknowledging the recently highlighted potential of radiomics and artificial intelligence (AI) tools as decision support for patient care in mCRC, a multidisciplinary, internatio…

PROTOCOLCancer ResearchPositron emission tomographyArtificial intelligenceConsensusBEVACIZUMABMedizinImagingCancer -- ImagingHumansCRITERIAColon (Anatomy) -- Cancer -- TomographyComputed tomographyScience & TechnologyRadiomicsRectal NeoplasmsAbdomen -- Radiography -- Case studiesColon (Anatomy) -- Cancer -- TreatmentReproducibility of ResultsAbdomen -- Radiography -- StandardsOPEN-LABELColorectal cancerArtificial intelligence Standardisation Colorectal cancer Computed tomography Imaging Positron emission tomography RadiomicsOncologyColonic NeoplasmsSURVIVALStandardisationLife Sciences & Biomedicine
researchProduct

Simultaneous confocal laser endomicroscopy and chromoendoscopy with topical cresyl violet

2009

Background Confocal laser endomicroscopy (CLE) has been shown to reliably predict histology during ongoing endoscopy. To unmask lesions for CLE, chromoendoscopy has been mandated. Usually fluorescein then serves as a contrast agent for CLE, but it does not allow direct nuclear visualization, must be injected, leads to a transient skin discoloration, and may have allergic side effects. Objective To establish a single topical dye, cresyl violet (CV), for simultaneous chromoendoscopy and in vivo CLE of the lower GI tract. Design Animal preclinical study, prospective clinical trial. Setting Mainz University Clinic (tertiary care center). Patients, Methods, and Interventions To establish the sta…

Pathologymedicine.medical_specialtyColonAdministration TopicalConfocalPilot ProjectsEndoscopy Gastrointestinallaw.inventionChromoendoscopyDiagnosis DifferentialMicechemistry.chemical_compoundCresyl violetIleumIn vivoConfocal microscopylawOxazinesEndomicroscopyAnimalsHumansMedicineRadiology Nuclear Medicine and imagingIntestinal MucosaFluoresceinColoring AgentsMicroscopy Confocalbusiness.industryGastroenterologyReproducibility of ResultsHistologyMiddle AgedBenzoxazinesIleal NeoplasmsDisease Models AnimalchemistryColonic NeoplasmsFemalebusinessCarcinoma in SituGastrointestinal Endoscopy
researchProduct

Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells.

1993

The expression of intercellular adhesion molecule-1 (ICAM-1, CD54) was examined in 16 surgically removed colonic tumours and two colonic carcinoma cell lines. Immunohistochemistry showed a varying percentage of ICAM-1 positive colonic carcinoma cells in 9/16 tissue specimens, while normal colonic tissue (apart from a slight reactivity of endothelial cells) was not stained. The presence of the ICAM-1 molecule on the cell surface and the expression of ICAM-1 mRNA were investigated for two colonic carcinoma cell lines. It was possible to enhance the expression of ICAM-1 considerably by incubating the cells in the presence of inflammatory cytokines in HT-29 and CaCo-2 cells. The responsiveness …

Pathologymedicine.medical_specialtyColonMolecular Sequence DataCellIntercellular Adhesion Molecule-1Alpha interferonBiologyInflammatory bowel diseaseEpitheliumProinflammatory cytokineTumor Cells CulturedmedicineHumansIntestinal MucosaBase SequenceGastroenterologyBlotting NorthernInflammatory Bowel DiseasesIntercellular Adhesion Molecule-1medicine.diseaseMolecular biologydigestive system diseasesEpitheliumNeoplasm Proteinsmedicine.anatomical_structureCell cultureColonic NeoplasmsImmunohistochemistryCell Adhesion MoleculesResearch ArticleGut
researchProduct

Epithelial cell proliferation index of the colonic mucosa in colonic diverticular disease

2006

Pathologymedicine.medical_specialtyColonic mucosamedicine.anatomical_structureHepatologyProliferation indexbusiness.industryCOLONIC DIVERTICULAR DISEASEGastroenterologymedicinebusinessEpitheliumDigestive and Liver Disease
researchProduct

Assessment of Tumor Development and Wound Healing Using Endoscopic Techniques in Mice

2010

Mouse models of intestinal inflammation and colon cancer are valuable tools to gain insights into the pathogenesis of the corresponding human diseases. Recently, in vivo mouse endoscopy has been developed, allowing not only the high-resolution monitoring and scoring of experimental disease development, but also enables the investigator to perform manipulations, including local injection of reagents or the taking of biopsies for molecular and histopathologic analyses. Chromoendoscopic staining with methylene blue enables visualization of the crypt structure and allows discrimination between inflammatory and neoplastic changes. The development of endoscopic techniques in live mice opened new …

Pathologymedicine.medical_specialtyColorectal cancerBiopsyDiseasePathogenesisMiceMicromanipulation03 medical and health sciences0302 clinical medicineIn vivoIntestinal inflammationmedicineAnimalsHumans030304 developmental biologyWound Healing0303 health sciencesMiniaturizationHepatologymedicine.diagnostic_testbusiness.industryDisease mechanismsGastroenterologyEndoscopyColitismedicine.disease3. Good healthEndoscopyEndoscopes GastrointestinalDisease Models AnimalColonic Neoplasms030211 gastroenterology & hepatologybusinessWound healingGastroenterology
researchProduct

Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case.

2011

Colon carcinoma rarely metastasizes to the breast and it is usually associated with a poor prognosis. Even rarer is metastatic seeding of colon cancer cells in an intramammary location after surgery. Including a primary breast malignancy in the differential diagnosis of such cases is mandatory. We report a rare case of double seeding implantation of colon adenocarcinoma inside the breast parenchyma and intercostal muscles 6 years after resection of a pulmonary metastasis from colon adenocarcinoma. The metastasis was revealed by the presence of bone metaplasia in the intercostal muscles. We discuss how negative immunostaining for estrogen receptors, progesterone receptors, and HER-2, along w…

Pathologymedicine.medical_specialtyColorectal cancerReceptor ErbB-2Estrogen receptorNeoplasm SeedingBreast NeoplasmsIntercostal MusclesSettore MED/08 - Anatomia PatologicaAdenocarcinomaBone and BonesMetastasisCytokeratinNeoplasm SeedingMetaplasiamedicineCarcinomaHumansAgedMetaplasiabusiness.industryGeneral MedicineThoracic Neoplasmsmedicine.diseasedigestive system diseasesSettore MED/18 - Chirurgia GeneraleMetastatic seeding colon adenocarcinoma breast cdx2ck20 ck7Receptors EstrogenColonic NeoplasmsSurgeryFemaleDifferential diagnosismedicine.symptombusinessReceptors ProgesteroneSurgery today
researchProduct